Responses
Poster Presentation
Rheumatoid arthritis - non biologic treatment
THU0248 Patient-Oriented Decision of Early Treatment of Rheumatoid Arthritis with Combination of Triple Conventional Disease Modifying Anti-Rheumatic Drugs or Tumor Necrosis Factor Inhibitors and Methotrexate (Prospective, Open-Label Clinical Trial)
Compose a Response to This Article
Other responses
No responses have been published for this article.